DECHRA PHARMACEUTICALS PLC SHS's ticker is and the CUSIP is G2769C145. A total of 1 filers reported holding DECHRA PHARMACEUTICALS PLC SHS in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,771 | -77.6% | 124,831 | -77.2% | 0.14% | -74.9% |
| Q2 2023 | $25,708 | -4.3% | 548,596 | -33.1% | 0.55% | -1.8% |
| Q1 2023 | $26,875 | +10564.7% | 820,222 | +10151.5% | 0.56% | +4558.3% |
| Q4 2022 | $252 | -99.9% | 8,001 | +2.1% | 0.01% | 0.0% |
| Q3 2022 | $229,000 | -30.4% | 7,834 | -0.1% | 0.01% | -25.0% |
| Q2 2022 | $329,000 | -21.5% | 7,838 | 0.0% | 0.02% | -11.1% |
| Q1 2022 | $419,000 | -25.6% | 7,838 | +0.5% | 0.02% | -21.7% |
| Q4 2021 | $563,000 | +6.6% | 7,802 | -3.4% | 0.02% | 0.0% |
| Q3 2021 | $528,000 | -37.2% | 8,076 | -42.1% | 0.02% | -36.1% |
| Q2 2021 | $841,000 | +8.5% | 13,937 | -14.9% | 0.04% | -26.5% |
| Q1 2021 | $775,000 | -13.4% | 16,371 | -13.7% | 0.05% | -21.0% |
| Q4 2020 | $895,000 | -27.5% | 18,973 | -36.0% | 0.06% | -47.0% |
| Q3 2020 | $1,235,000 | +19.4% | 29,639 | +0.8% | 0.12% | +6.4% |
| Q2 2020 | $1,034,000 | +15.7% | 29,411 | -4.1% | 0.11% | -12.7% |
| Q1 2020 | $894,000 | -15.3% | 30,653 | +11.6% | 0.13% | +2.4% |
| Q4 2019 | $1,056,000 | +74.5% | 27,478 | +54.9% | 0.12% | +64.0% |
| Q3 2019 | $605,000 | +14.2% | 17,742 | +16.9% | 0.08% | +13.6% |
| Q2 2019 | $530,000 | -0.6% | 15,179 | +0.2% | 0.07% | -4.3% |
| Q1 2019 | $533,000 | – | 15,154 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Boston Common Asset Management, LLC | 7,838 | $419,000 | 0.02% |